GuiZhou SanLi Pharmaceutical Co.,Ltd

Shanghai Stock Exchange 603439.SS

GuiZhou SanLi Pharmaceutical Co.,Ltd Net Cash Used For Investing Activities for the year ending December 31, 2023: USD -86.45 M

GuiZhou SanLi Pharmaceutical Co.,Ltd Net Cash Used For Investing Activities is USD -86.45 M for the year ending December 31, 2023, a -123.81% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.

GuiZhou SanLi Pharmaceutical Co.,Ltd Net Cash Used For Investing Activities for the year ending December 31, 2022 was USD -38.63 M, a -1,291.97% change year over year.
GuiZhou SanLi Pharmaceutical Co.,Ltd Net Cash Used For Investing Activities for the year ending December 31, 2021 was USD 3.24 M, a 107.22% change year over year.
GuiZhou SanLi Pharmaceutical Co.,Ltd Net Cash Used For Investing Activities for the year ending December 31, 2020 was USD -44.86 M, a -5,026.83% change year over year.
GuiZhou SanLi Pharmaceutical Co.,Ltd Net Cash Used For Investing Activities for the year ending December 31, 2019 was USD -874.97 K, a 87.36% change year over year.

Key data

Date	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure

Shanghai Stock Exchange: 603439.SS

GuiZhou SanLi Pharmaceutical Co.,Ltd

CEO	Mr. Hai Zhang
IPO Date	April 28, 2020
Location	China
Headquarters	Xiayun Industrial Park
Employees	2,282
Sector	Health Care
Industries Pharmaceuticals

Description

GuiZhou SanLi Pharmaceutical Co.,LTD. engages in the research and development, production, and marketing of pharmaceutical products. It offers pediatric medication, respiratory system medication, cardiovascular and cerebrovascular drugs, digestive medicine, trauma injury medication, rehabilitation medicine, and ophthalmic medicine. The company was founded in 1995 and is based in Guiyang, China.

Key trends

Past 5 years